GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (INGN) (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...
Inogen estimates preliminary, unaudited total revenue of about $82 million for the fourth quarter of ...
Zacks Investment Research on MSN
Here's why you should add Inogen stock to your portfolio now
Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator ...
It has been about a month since the last earnings report for Inogen (INGN). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...
Stifel Nicolaus analyst Mathew Blackman maintained a Hold rating on Inogen (INGN – Research Report) yesterday and set a price target of $10.00. Discover outperforming stocks and invest smarter with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback